Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

A little-known safe, and potentially life-saving drug for treating patients with severe, late-stage COVID, was purposefully ignored by U.S. health officials, and a group of Congressional Republicans led by Wisconsin Senator Ron Johnson are demanding to know why.

ZYESAMI (off-patent aviptadil) has shown promise as a treatment for COVID patients who are suffering with severe lung inflammation following an excessive immune response known as a “cytokine storm.” The drug is available through the “Right to Try” law—passed by Congress in 2018—but the Food and Drug Administration (FDA), and National Institute of Allergy and Infectious Diseases (NIAID) have failed to recommend it, so it remains largely unknown as a treatment option.

Unlike repurposed drugs like Hydroxychloroquine, and Ivermectin, before the pandemic, Aviptadil already had a track record for treating pulmonary inflammation conditions.

https://thejewishvoice.com/2022/03/in-letter-to-fda-and-niaid-ron-johnson-demands-to-know-why-promising-late-stage-covid-drug-was-never-approved/

A Pilot who went for his first yearly physical after receiving his vaccine was told he now has a heart condition – after 20 years of perfect health.

https://dailyclout.io/adverse-events-heavy-landing-pilot-in-perfect-health-until-vaccine/